Literature DB >> 30631077

Coeliac disease.

Katri Lindfors1, Carolina Ciacci2, Kalle Kurppa3, Knut E A Lundin4, Govind K Makharia5, M Luisa Mearin6, Joseph A Murray7, Elena F Verdu8, Katri Kaukinen9.   

Abstract

Coeliac disease is an immune-mediated enteropathy against dietary gluten present in wheat, rye and barley and is one of the most common lifelong food-related disorders worldwide. Coeliac disease is also considered to be a systemic disorder characterized by a variable combination of gluten-related signs and symptoms and disease-specific antibodies in addition to enteropathy. The ingestion of gluten leads to the generation of harmful gluten peptides, which, in predisposed individuals, can induce adaptive and innate immune responses. The clinical presentation is extremely variable; patients may have severe gastrointestinal symptoms and malabsorption, extraintestinal symptoms or have no symptoms at all. Owing to the multifaceted clinical presentation, diagnosis remains a challenge and coeliac disease is heavily underdiagnosed. The diagnosis of coeliac disease is achieved by combining coeliac disease serology and small intestinal mucosal histology during a gluten-containing diet. Currently, the only effective treatment for coeliac disease is a lifelong strict gluten-free diet; however, the diet is restrictive and gluten is difficult to avoid. Optimizing diagnosis and care in coeliac disease requires continuous research and education of both patients and health-care professionals.

Entities:  

Mesh:

Year:  2019        PMID: 30631077     DOI: 10.1038/s41572-018-0054-z

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   52.329


  66 in total

Review 1.  Celiac disease in the East and the West: Bridging the gaps between the guidelines and their implementation in daily practice is mandatory.

Authors:  Anmol Dhawan; Ashish Agarwal; Chris J Mulder; Govind K Makharia
Journal:  Indian J Gastroenterol       Date:  2019-06

2.  Hydroxychloroquine inhibits the mitochondrial antioxidant system in activated T cells.

Authors:  Man Lyang Kim; Melinda Y Hardy; Laura E Edgington-Mitchell; Sri H Ramarathinam; Shan Zou Chung; Amy K Russell; Iain Currie; Brad E Sleebs; Anthony W Purcell; Jason A Tye-Din; Ian P Wicks
Journal:  iScience       Date:  2021-11-25

3.  A high-affinity human TCR-like antibody detects celiac disease gluten peptide-MHC complexes and inhibits T cell activation.

Authors:  Rahel Frick; Lene S Høydahl; Jan Petersen; M Fleur du Pré; Shraddha Kumari; Grete Berntsen; Alisa E Dewan; Jeliazko R Jeliazkov; Kristin S Gunnarsen; Terje Frigstad; Erik S Vik; Carmen Llerena; Knut E A Lundin; Sheraz Yaqub; Jørgen Jahnsen; Jeffrey J Gray; Jamie Rossjohn; Ludvig M Sollid; Inger Sandlie; Geir Åge Løset
Journal:  Sci Immunol       Date:  2021-08-20

4.  Nanomaterials for antigen-specific immune tolerance therapy.

Authors:  Jinwon Park; Yina Wu; Qiaoyun Li; Jaehyun Choi; Hyemin Ju; Yu Cai; Jaiwoo Lee; Yu-Kyoung Oh
Journal:  Drug Deliv Transl Res       Date:  2022-09-12       Impact factor: 5.671

5.  CD38 expression on gluten-specific T cells is a robust marker of gluten re-exposure in coeliac disease.

Authors:  Stephanie Zühlke; Louise Fremgaard Risnes; Shiva Dahal-Koirala; Asbjørn Christophersen; Ludvig M Sollid; Knut Ea Lundin
Journal:  United European Gastroenterol J       Date:  2019-09-07       Impact factor: 4.623

6.  Fecal and Duodenal Microbiota in Pediatric Celiac Disease.

Authors:  Diyora Abdukhakimova; Kuanysh Dossybayeva; Dimitri Poddighe
Journal:  Front Pediatr       Date:  2021-04-22       Impact factor: 3.418

7.  Mobile Application for Promoting Gluten-Free Diet Self-Management in Adolescents with Celiac Disease: Proof-of-Concept Study.

Authors:  Sonya Meyer; Gali Naveh
Journal:  Nutrients       Date:  2021-04-21       Impact factor: 5.717

8.  Celiac Disease in Asia beyond the Middle East and Indian subcontinent: Epidemiological burden and diagnostic barriers.

Authors:  Dimitri Poddighe; Diyora Abdukhakimova
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

9.  Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy.

Authors:  Rakel Nurmi; Ilma Korponay-Szabó; Kaija Laurila; Heini Huhtala; Onni Niemelä; Jukka Mustonen; Satu Mäkelä; Katri Kaukinen; Katri Lindfors
Journal:  Nutrients       Date:  2021-05-11       Impact factor: 5.717

10.  Coeliac Disease: A Subtle yet Life Changing Diagnosis.

Authors:  Dilhara Karunaratne
Journal:  J Patient Exp       Date:  2021-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.